Bisaro Paul Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
3
Insider Buys Sum
$299,990.00
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Bisaro Paul

According to the SEC Form 4 filings, Bisaro Paul, being in a position of

  1. director at Myriad Genetics, Inc.,
    оver the last 12 months, has bought 7500 shares for $27,638, and sold 0 shares,
    over all time since 2026-05-14, has bought 7500 shares for $27,638, and sold 0 shares.

Biography of Bisaro Paul

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $179,3882100
Sells
 $000

Comparison of Insiders on Amount of Buys and Sells

2026-05-14PurchaseMyriad Genetics, Inc.
MYGN
director
7,500
0.0078%
$3.69$27,638+17.4%
2026-05-13PurchaseZoetis Inc.
ZTS
director
2,000
0.0005%
$75.88$151,750+2.86%
2021-08-16PurchaseTherapeuticsMD, Inc.
TXMD
director
50,000
0.0002%
$0.79$39,500-56.41%
2020-06-04PurchaseTherapeuticsMD, Inc.
TXMD
director
50,000
0.0004%
$1.14$57,000+22.32%
2019-03-12PurchaseAmneal Pharmaceuticals, Inc.
AMRX
Executive Chairman
17,000
0.013%
$11.97$203,490-63.27%
Total: 5
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.